1. National Laboratory of Rare Earth Material Chemistry and Application, College of Chemical and Molecular Engineering, Peking University, Beijing 100871, China 2. Applied Chemistry Department, School of Science, Beijing University of Chemical Technology, Beijing 100029, China 3. Beijing Institute of Microchemistry, Beijing 100091, China
Abstract:Ofloxacin ((±)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) is a totally synthetic fluoroquinolone antimicrobial agent with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and atypical pathogens such as Mycoplasma, Chlamydia and Legionella. Even though it is widely used for the treatment of gastrointestinal, pulmonary, urinary, and other infections, the comprehensive mechanism of action at molecular level has not been known so far. It is very important to understand the structural characteristics of the drug and the effects that are caused by the environments. With the purpose of deeply investigating the structure of Ofloxacin, an analog of Ofloxacin, Methyl-Ofloxacin (Me-OFL), was synthesized by methylation of 4’N in piperazine ring from Ofloxacin with CH3I. Then appropriate Me-OFL was dissolved in DCl/D2O and NaOH/D2O to prepare corresponding acidic and alkaline solutions. Systematic NMR spectroscopic investigation on Me-OFL in both acidic and alkaline solution was conducted using quantitative 1H and 13C spectra, DEPT, HSQC together with HMBC techniques. The spectra were recorded with Bruker AM-300 spectrometer and DRX500 spectrometer. Chemical shifts have been given in values referred to dioxane (δH=3.7, δC=67.8). Complete assignments on 1H and 13C signals of Me-OFL were obtained in different pH environments where the coupling constant between 13C and 19F was found to be very helpful for the assignment of aromatic 13C signals. A comprehensive comparison between the 1H, 13C chemical shifts, together with the structural transformation in acidic and alkaline solutions was made and discussed in details. Due to the formation of hydrogen bond between COOH and CO, the COOH and aromatic ring are in the same plane. As a result, a weak O…H—C hydrogen bond forms between CO from the carboxyl group and 5-H from aromatic ring. In alkaline solution, the deprivation of H+ from COOH destroys not only the hydrogen bond between COOH and carbonyl group but also the weak hydrogen between the CO from COOH and 5H. As a result, the 5H exhibited remarkable shift toward high field (1.02). Meanwhile, the chemical shift of 6C, 13C, 7C, 15C also exhibited remarkable shift to low field at 12.04, 7.46, 4.33, 2.88 respectively. Such variations were related to the changes of p electrons from carboxyl group caused by the transformation between the carboxyl group and the carboxylate group in different pH environments. Comparison of δH,δC data between Me-OFL and OFL in acidic solution and OFL in alkaline was made. In Me-OFL acidic solution, the chemical shift of 3’C,5’C,7’C,8’C also exhibited remarkable shift to low field at 6.66-7.32 respectively, the chemical shift of 2’C and 6’C also exhibited remarkable shift to high field 6.04. In OFL acidic solution, the chemical shift of 2’C, 3’C, 5’C, 6’C, 7’C, 8’C also exhibited remarkable shift to high field within 2.39, Comparison between the protonation and the methylation on the 4’N atom from the piperazine ring was also made. The distribution of positive charge also showed difference. When protonation occurred on the piperazine ring, the positive charge was on the proton connected with 4’N. However, if methylation occurred, the positive charge is on the 4’-N atom.
Key words:Quinolone;Methyl-Ofloxacin;NMR;Piperazine ring
高秀香1,齐剑1,赵梅仙2,涂光中3,安东各3,徐怡庄1*,吴瑾光1. 氧氟沙星甲基化物的核磁共振波谱研究[J]. 光谱学与光谱分析, 2008, 28(06): 1420-1425.
GAO Xiu-xiang1,QI Jian1,ZHAO Mei-xian2,TU Guang-zhong3,AN Dong-ge3,XU Yi-zhuang1*,WU Jin-guang1. A Study on the NMR Spectrum of Methyl-Ofloxacin. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2008, 28(06): 1420-1425.
[1] Neugebauer U, Szeghalmi A, Schmitt M, et al. Spectrochimica Acta Part A, 2005, 61: 1505. [2] Mucci A, Malmusi L, Vandelli M A, et al. Medicinal Chemistry Research, 1996, 6(5): 353. [3] Fardella G, Barbetti P, Chiappini I, et al. International Journal of Pharmaceutics, 1995, 121: 123. [4] Masahiro Sakai, Akihiro Hara, Saeko Anjo, et al. Journal of Pharmaceutical and Biomedical Analysis, 1999, 18:1057. [5] Iztok Turel. Coordination Chemistry Reviews, 2002, 232(27): 22. [6] Macias B, Villa M V, Sastre M, et al. Journal of Pharmaceutical Sciences, 2002, 91(11): 2416. [7] Koester L S, Guterres S S, Le Roch M, et al. Drug Development and Industrial Pharmacy, 2001, 27(6): 533. [8] Sagdine S, Bayari S. Journal of Molecular Structure, 2004, 691: 107. [9] LIU Ming-liang(刘明亮). World Notes on Antibiotics(国外医药抗生素分册), 2006, 27(1): 22. [10] LI Wen, BAN Yun-dong, SHA Yi, et al(李 文, 班允东, 沙 沂, 等). Chinese J. of Pharm.(中国医药工业杂志), 1999, 30(9): 407. [11] ZHANG Guo-wen, NI Yong-nian(张国文, 倪永年). Spectroscopy and Spectral Analysis(光谱学与光谱分析), 2006, 26(1): 114. [12] YANG Jun, XU Yi-zhuang, WENG Shi-fu, et al(杨 军, 徐怡庄, 翁诗甫, 等). Spectroscopy and Spectral Analysis(光谱学与光谱分析), 2002, 22(5): 741. [13] QI Jian, GAO Xiu-xiang, ZHAO Mei-xian, et al(齐 剑, 高秀香, 赵梅仙, 等). Chemical Journal of Chinese Universities(高等学校化学学报), 2007, 28(5): 913. [14] LIU Cui-ge, XU Yi-zhuang, WEI Yong-ju, et al(刘翠格, 徐怡庄, 魏永巨, 等). Spectroscopy and Spectral Analysis(光谱学与光谱分析), 2005, 25(4): 584. [15] HE Li-qin, CHEN Tian-yu, XIAN Yu-juan(何黎琴, 陈天宇, 见玉娟). Anhui Chemical Industry(安徽化工), 2004, 30(6): 22. [16] ZHAO Tian-zeng(赵天增). Proton NMR Spectroscopy(核磁共振氢谱). Beijing: Peking University Press(北京: 北京大学出版社), 1983. 64. [17] ZHU Huai-wu(朱淮武). Structural Analysis of Organic Molecules by NMR Methods(有机分子结构波谱解析). Beijing: Chemical Industry Press(北京: 化学工业出版社), 2005. 149. [18] SHEN Qi-feng(沈其丰). 13C NMR Spectroscopy(核磁共振碳谱). Beijing: Peking University Press(北京: 北京大学出版社), 1988. 88.